Cargando…

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study

Detalles Bibliográficos
Autores principales: Suruki, Robert Y, Desai, Rishi J, Davis, Kourtney J, Berlin, Jesse A, Gagne, Joshua J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348766/
https://www.ncbi.nlm.nih.gov/pubmed/35333307
http://dx.doi.org/10.1093/rheumatology/keac157
_version_ 1784761986194604032
author Suruki, Robert Y
Desai, Rishi J
Davis, Kourtney J
Berlin, Jesse A
Gagne, Joshua J
author_facet Suruki, Robert Y
Desai, Rishi J
Davis, Kourtney J
Berlin, Jesse A
Gagne, Joshua J
author_sort Suruki, Robert Y
collection PubMed
description
format Online
Article
Text
id pubmed-9348766
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93487662022-08-04 Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study Suruki, Robert Y Desai, Rishi J Davis, Kourtney J Berlin, Jesse A Gagne, Joshua J Rheumatology (Oxford) Published Online Only Oxford University Press 2022-03-25 /pmc/articles/PMC9348766/ /pubmed/35333307 http://dx.doi.org/10.1093/rheumatology/keac157 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Published Online Only
Suruki, Robert Y
Desai, Rishi J
Davis, Kourtney J
Berlin, Jesse A
Gagne, Joshua J
Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
title Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
title_full Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
title_fullStr Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
title_full_unstemmed Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
title_short Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
title_sort comment on: risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
topic Published Online Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348766/
https://www.ncbi.nlm.nih.gov/pubmed/35333307
http://dx.doi.org/10.1093/rheumatology/keac157
work_keys_str_mv AT surukiroberty commentonriskofmajoradversecardiovasculareventsinpatientsinitiatingbiologicsapremilastforpsoriaticarthritisanationwidecohortstudy
AT desairishij commentonriskofmajoradversecardiovasculareventsinpatientsinitiatingbiologicsapremilastforpsoriaticarthritisanationwidecohortstudy
AT daviskourtneyj commentonriskofmajoradversecardiovasculareventsinpatientsinitiatingbiologicsapremilastforpsoriaticarthritisanationwidecohortstudy
AT berlinjessea commentonriskofmajoradversecardiovasculareventsinpatientsinitiatingbiologicsapremilastforpsoriaticarthritisanationwidecohortstudy
AT gagnejoshuaj commentonriskofmajoradversecardiovasculareventsinpatientsinitiatingbiologicsapremilastforpsoriaticarthritisanationwidecohortstudy